Promising Anti-influenza Properties of Active Constituent of Withania somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study - PubMed (original) (raw)
Promising Anti-influenza Properties of Active Constituent of Withania somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study
Zhi Cai et al. Cell Biochem Biophys. 2015 Jul.
Abstract
Neuraminidase (NA) is a membrane surface antigen which helps in the release of influenza viruses from the host cells after replication. Anti-influenza drugs such as zanamivir bind with eight highly conserved functional residues (R118, D151, R152, R224, E276, R292, R371, and Y406) in the active site of NA, thus restricting the viral release the from host cells. Binding of the drug in active site inhibits the ability of enzyme to cleave sialic acid residues on the cell membrane. Reports on the emergence of zanamivir-resistant strains of H1N1 Influenza virus necessitated a search for alternative drug candidates, preferably from plant source due to their known benefits such as less or no side effects, availability, and low cost. Withaferin A (WA), an active constituent of Withania somnifera ayurvedic herb, has been shown to have a broad range of medicinal properties including its anti-viral activity. The present study demonstrated that WA has the potential to attenuate the neuraminidase of H1N1 influenza. Our docking and simulation results predicted high binding affinity of the WA toward NA and revealed several interesting molecular interactions with the residues which are catalytically important during molecular dynamic simulations. The results presented in the article could be of high importance for further designing of target-specific anti-influenza drug candidates.
Keywords: Anti-influenza; Docking; Molecular dynamic simulations; Neuraminidase; Swine flu; Withaferin A; Withania somnifera.
Similar articles
- In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain.
Hussain Basha S, Prasad RN. Hussain Basha S, et al. BMC Res Notes. 2012 Feb 17;5:105. doi: 10.1186/1756-0500-5-105. BMC Res Notes. 2012. PMID: 22340192 Free PMC article. - Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
Meeprasert A, Khuntawee W, Kamlungsua K, Nunthaboot N, Rungrotmongkol T, Hannongbua S. Meeprasert A, et al. J Mol Graph Model. 2012 Sep;38:148-54. doi: 10.1016/j.jmgm.2012.06.007. Epub 2012 Jul 4. J Mol Graph Model. 2012. PMID: 23079644 - Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs.
Dholakia D, Goyal S, Jamal S, Singh A, Das A, Grover A. Dholakia D, et al. BMC Bioinformatics. 2016 Dec 22;17(Suppl 19):512. doi: 10.1186/s12859-016-1374-1. BMC Bioinformatics. 2016. PMID: 28155702 Free PMC article. - Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
Feng E, Ye D, Li J, Zhang D, Wang J, Zhao F, Hilgenfeld R, Zheng M, Jiang H, Liu H. Feng E, et al. ChemMedChem. 2012 Sep;7(9):1527-36. doi: 10.1002/cmdc.201200155. Epub 2012 Jul 16. ChemMedChem. 2012. PMID: 22807317 Review. - Influenza virus resistance to neuraminidase inhibitors.
Samson M, Pizzorno A, Abed Y, Boivin G. Samson M, et al. Antiviral Res. 2013 May;98(2):174-85. doi: 10.1016/j.antiviral.2013.03.014. Epub 2013 Mar 22. Antiviral Res. 2013. PMID: 23523943 Review.
Cited by
- Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents.
Gabbianelli R, Shahar E, de Simone G, Rucci C, Bordoni L, Feliziani G, Zhao F, Ferrati M, Maggi F, Spinozzi E, Mahajna J. Gabbianelli R, et al. Nutrients. 2023 Nov 8;15(22):4719. doi: 10.3390/nu15224719. Nutrients. 2023. PMID: 38004113 Free PMC article. Review. - Withania somnifera extracts induced attenuation of HIV-1: a mechanistic approach to restrict viral infection.
Jadaun P, Harshithkumar R, Gaikwad SY, Seniya C, Borse S, Gawai AA, Chavan-Gautam P, Tillu G, Mukherjee A. Jadaun P, et al. Virol J. 2023 Aug 3;20(1):173. doi: 10.1186/s12985-023-02130-y. Virol J. 2023. PMID: 37537596 Free PMC article. - COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery.
Kumar S, Basu M, Ghosh P, Pal U, Ghosh MK. Kumar S, et al. Genes Dis. 2023 Jul;10(4):1402-1428. doi: 10.1016/j.gendis.2022.12.019. Epub 2023 Apr 7. Genes Dis. 2023. PMID: 37334160 Free PMC article. Review. - In silico analysis and molecular docking studies of natural compounds of Withania somnifera against bovine NLRP9.
Ali A, Mir GJ, Ayaz A, Maqbool I, Ahmad SB, Mushtaq S, Khan A, Mir TM, Rehman MU. Ali A, et al. J Mol Model. 2023 May 8;29(6):171. doi: 10.1007/s00894-023-05570-z. J Mol Model. 2023. PMID: 37155030 Free PMC article. - A systemic review on medicinal plants and their bioactive constituents against avian influenza and further confirmation through in-silico analysis.
Dutta AK, Gazi MS, Uddin SJ. Dutta AK, et al. Heliyon. 2023 Mar 10;9(3):e14386. doi: 10.1016/j.heliyon.2023.e14386. eCollection 2023 Mar. Heliyon. 2023. PMID: 36925514 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources